PMC-Sierra: PMCS is making a comeback, Cramer said. He thinks investors should also be in Cisco Systems because PMCS products go into CSCO.
Vertex Pharmaceuticals: VRTX is not a bad stock, but Cramer would rather see investor's in Gilead Sciences.
North American Palladium: Cramer said investors should only think of PAL as a spec play because there is not a lt of information about this Canadain stock.
Cramer's charitable trust owns Gilead Sciences and Cisco Systems.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the Mad Money website? email@example.com